-
CREC Carbapenemase Transmission in Guangdong
2026-09-22
Chen et al. integrated gene localization, conjugation testing, mobile-element analysis, antimicrobial susceptibility testing, and ERIC-PCR genotyping to characterize carbapenem-resistant Enterobacter cloacae across eight Guangdong teaching hospitals. The study identifies plasmid-associated blaNDM-1 as a major transmission concern and provides a practical framework for interpreting horizontal transfer, clonal relatedness, and multidrug resistance in antimicrobial resistance research.
-
Tropisetron and Renal OCT2/MATE1 Inhibition
2026-09-22
George and colleagues evaluated five 5-HT3 antagonists as inhibitors of the renal organic cation transporters OCT2 and MATE1 using engineered cell systems. The study shows that transporter inhibition varies substantially by compound and transporter, providing a mechanistic basis for investigating altered renal secretion and possible drug–drug interactions.
-
CSBTA Pharmacokinetics in MASH Mice
2026-09-21
The reference study integrates pharmacokinetics, tissue distribution, transporter assays, and drug-metabolizing enzyme analysis to explain how HFHCD-induced MASH alters the disposition of Corydalis saxicola Bunting total alkaloids. Its findings show that disease state and repeated dosing can increase systemic exposure, hepatocyte accumulation, and liver distribution, providing a mechanistic basis for dose-regimen refinement.
-
METTL16–SENP3–LTF Axis in HCC Ferroptosis
2026-09-21
Wang et al. identify a METTL16–SENP3–LTF pathway that lowers labile iron and protects hepatocellular carcinoma (HCC) cells from ferroptosis. By combining molecular assays, organoids, xenografts, genetically engineered mice, and human samples, the study links an m6A-dependent RNA mechanism to iron handling and tumor progression.
-
(S)-(+)-Dimethindene maleate Workflow Guide
2026-09-20
This practical guide explains how to use (S)-(+)-Dimethindene maleate as a research antagonist when M2 muscarinic activity must be interpreted alongside histamine H1 activity. It is suited to controlled receptor, autonomic, cardiovascular, and respiratory workflows, but not to diagnostic, therapeutic, or clinical use.
-
HyperScribe T7 High Yield Cy5 RNA Labeling Kit Guide
2026-09-19
Learn how to use the HyperScribe T7 High Yield Cy5 RNA Labeling Kit for spatial transcript detection, Northern blot validation, and quality control in TREM2 macrophage studies. The workflow emphasizes tunable Cy5-UTP incorporation, assay-specific probe design, and practical troubleshooting rather than treating fluorescence intensity as a standalone biological readout.
-
ATS-9R Workflow for Adipose Gene Silencing
2026-09-18
ATS-9R enables targeted, non-viral nucleic-acid delivery to white adipose tissue and adipose tissue macrophages, creating a practical route for obesity-associated inflammation research. This guide translates its Prohibitin-mediated uptake mechanism into reproducible complexing, validation, in vivo dosing, and troubleshooting workflows.
-
Purmorphamine: From Smoothened Biology to Translation
2026-09-18
Purmorphamine is more than a pathway agonist: it is a controllable Smoothened perturbation tool for connecting Hedgehog signaling with osteogenic phenotypes, sensory biology, and translational assay design.
-
Vardenafil HCl Trihydrate: PDE5 Assay Guide
2026-09-17
Vardenafil HCl Trihydrate is a potent, selective PDE5 inhibitor for enzyme, cGMP signaling pathway, and smooth muscle relaxation research. Supplier-reported biochemical data show a 0.7 nM PDE5 IC50, while native-membrane proteoform work highlights the need to evaluate PDE6-related off-target interactions in physiologically relevant systems.
-
Protoporphyrin IX: A Causal Assay Guide
2026-09-17
Protoporphyrin IX is a photodynamic compound at the intersection of heme formation, porphyrin biology, and ferroptosis research. This guide presents a causal assay framework for separating light-dependent effects from iron and heme-related mechanisms, with practical guidance for SKU B8225.
-
Mestranol, Microglia, and Reversible Lysosomal Stress
2026-09-16
The reference study identifies mestranol as an inducer of a reversible lysosomal storage–like state in zebrafish microglia, separating defective intracellular digestion from loss of phagocytic uptake or increased neuronal apoptosis. Its live-imaging, functional, transcriptomic, and TFEC-rescue framework provides a useful model for investigating environmental estrogenic neuroimmunotoxicity and microglial lysosomal vulnerability.
-
Gly-Gly-Phe-Gly (GGFG) Workflow Guide
2026-09-16
Build more controllable bioconjugation workflows with Gly-Gly-Phe-Gly, a flexible short-chain spacer for drug conjugation, antibody engineering, and biomaterial design. This guide connects practical GGFG handling with assay logic inspired by a preclinical panobinostat combination study—while clearly separating established evidence from application-specific recommendations.
-
Mitochondrial Permeability Transition Pore Assay Kit Guide
2026-09-15
Translate mitochondrial pore opening into a practical fluorescence workflow for hepatocyte injury, drug-response studies, and cell death mechanism research. This guide combines Calcein AM/cobalt quenching with orthogonal apoptosis, ROS, and mitochondrial function measurements for more defensible conclusions.
-
Pentoxifylline Modulates Preterm Monocyte Inflammation
2026-09-15
This study shows that Pentoxifylline suppresses LPS-driven inflammatory activation in monocytes from preterm infants by reducing TLR4 expression and signaling. Its age-stratified design reveals that preterm monocytes may respond differently from term-infant and adult cells, providing a mechanistic basis for evaluating this phosphodiesterase inhibitor in neonatal sepsis research.
-
GCG Disrupts SARS-CoV-2 N-Protein Condensation
2026-09-14
The reference study identifies RNA-triggered liquid–liquid phase separation of the SARS-CoV-2 nucleocapsid protein as a mechanistic step in viral biology and shows that gallocatechin gallate can disrupt this condensate. Its combination of protein-wide prediction, biochemical reconstitution, viral infection experiments, and genome-variant analysis provides a framework for studying nucleocapsid condensation as a potential antiviral target.